-
![Amino-substituted imidazo[1,2-A] pyridinecarboxamides and their use](/abs-image/US/2020/05/26/US10662185B2/abs.jpg.150x150.jpg)
公开(公告)号：US10662185B2
公开(公告)日：2020-05-26
申请号：US16025087
申请日：2018-07-02
发明人： Alexandros Vakalopoulos , Markus Follman , Ingo Hartung , Philipp Buchgraber , Rolf Jautelat , Jorma Haßfeld , Niels Lindner , Alexey Gromov , Frank Wunder , Johannes-Peter Stasch , Gorden Redlich , Volkhart Min-Jian Li , Eva Maria Becker-Pelster , Andreas Knorr
IPC分类号： C07D471/04 , A61K31/437 , A61K31/439 , A61K31/4985 , A61K45/06 , C07D471/08 , A61K31/496 , A61K31/5377 , A61K31/541 , C07D519/00 , A61K31/444 , A61K31/4545 , A61K31/4709 , A61K31/55 , A61K31/4375 , A61K31/4725
摘要： The present application relates to novel substituted imidazo[1,2-a]pyridine-3-carboxamides of the general formula (I) to processes for their preparation, to their use alone or in combinations for the treatment and/or prophylaxis of diseases and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of cardiovascular disorders.
-
公开(公告)号：US10668071B2
公开(公告)日：2020-06-02
申请号：US16101250
申请日：2018-08-10
发明人： Jorma Haßfeld , Tom Kinzel , Johannes Köbberling , Yolanda Cancho-Grande , Kristin Beyer , Susanne Röhrig , Maria Köllnberger , Michael Sperzel , Nils Burkhardt , Karl-Heinz Schlemmer , Christian Stegmann , Joachim Schuhmacher , Matthias Werner , Manuel Ellermann
IPC分类号： A61K31/519 , A61K45/06 , C07D487/04 , C07D487/12 , C07D471/14
摘要： The present application relates to novel substituted (aza)pyridopyrazolopyrimidinones and indazolopyrimidinones, to processes for their preparation, the compounds for use alone or in combinations in a method for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of acute and recurrent bleeding in patients with or without underlying hereditary or acquired bleeding disorders, wherein the bleeding is associated with a disease or medical intervention selected from the group consisting of menorrhagia, postpartum hemorrhage, hemorrhagic shock, trauma, surgery, transplantation, stroke, liver diseases, hereditary angioedema, nosebleed, and synovitis and cartilage damage following hemarthrosis.
-
3.发明申请(Aza)pyridopyrazolopyrimidinones and indazolopyrimidinones and their use 有权（氮杂）吡唑并吡咯并嘧啶酮和吲唑并嘧啶酮及其用途公开(公告)号：US20150126449A1
公开(公告)日：2015-05-07
申请号：US14533915
申请日：2014-11-05
发明人： Jorma Haßfeld , Tom KINZEL , Johannes Köbberling , Yolanda CANCHO GRANDE , Kristin BEYER , Susanne Röhrig , Maria Köllnberger , Michael SPERZEL , Nils BURKHARDT , Karl-Heinz SCHLEMMER , Christian STEGMANN , Joachim SCHUHMACHER , Matthias WERNER , Manuel ELLERMANN
IPC分类号： C07D487/04 , C07D471/14 , A61K45/06 , A61K31/519
CPC分类号： A61K31/519 , A61K45/06 , C07D471/14 , C07D487/04 , C07D487/12
摘要： The present application relates to novel substituted (aza)pyridopyrazolopyrimidinones and indazolopyrimidinones, to processes for their preparation, the compounds for use alone or in combinations in a method for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of acute and recurrent bleeding in patients with or without underlying hereditary or acquired bleeding disorders, wherein the bleeding is associated with a disease or medical intervention selected from the group consisting of menorrhagia, postpartum hemorrhage, hemorrhagic shock, trauma, surgery, transplantation, stroke, liver diseases, hereditary angioedema, nosebleed, and synovitis and cartilage damage following hemarthrosis.
摘要翻译： 本申请涉及新的取代的（氮杂）吡啶并吡咯并嘧啶酮和吲唑并嘧啶酮，其制备方法，单独使用的化合物或用于治疗和/或预防疾病，特别是用于治疗和/或预防的方法中的组合 具有或不具有潜在遗传性或获得性出血性疾病的患者的急性和复发性出血，其中所述出血与选自月经过多，产后出血，出血性休克，创伤，手术，移植，中风， 肝脏疾病，遗传性血管性水肿，流鼻血和关节炎后的滑膜炎和软骨损伤。
-
公开(公告)号：US10118930B2
公开(公告)日：2018-11-06
申请号：US15523954
申请日：2015-10-30
发明人： Manuel Ellermann , Gaelle Valot , Yolanda Cancho Grande , Jorma Haßfeld , Tom Kinzel , Johannes Köbberling , Kristin Beyer , Susanne Röhrig , Michael Sperzel , Jan Stampfuß , Imke Meyer , Maria Köllnberger , Nils Burkhardt , Karl-Heinz Schlemmer , Christian Stegmann , Joachim Schuhmacher , Matthias Werner , Jörg Heiermann , Willem Jan Hengeveld
IPC分类号： A01N43/90 , A61K31/519 , C07D487/04 , C07D471/04 , C07D211/06 , C07D403/14 , C07D231/00 , C07D247/02 , C07D271/06 , C07D271/10
摘要： The present application relates to novel substituted piperidinylpyrazolopyrimidinones, to processes for their preparation, the compounds for use alone or in combinations in a method for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of acute and recurrent bleeding in patients with or without underlying hereditary or acquired hemostatic disorders, wherein the bleeding is associated with a disease or medical intervention selected from the group consisting of heavy menstrual bleeding, postpartum hemorrhage, hemorrhagic shock, hemorrhagic cystitis, gastrointestinal hemorrhage, trauma, surgery, transplantation, stroke, liver diseases, hereditary angioedema, nosebleed, and synovitis and cartilage damage following hemarthrosis.
-
公开(公告)号：US10098883B2
公开(公告)日：2018-10-16
申请号：US15416651
申请日：2017-01-26
发明人： Jorma Haßfeld , Tom Kinzel , Johannes Köbberling , Yolanda Cancho-Grande , Kristin Beyer , Susanne Röhrig , Maria Köllnberger , Michael Sperzel , Nils Burkhardt , Karl-Heinz Schlemmer , Christian Stegmann , Joachim Schuhmacher , Matthias Werner , Manuel Ellermann
IPC分类号： A61K31/519 , A61K45/06 , C07D487/12 , C07D471/14 , C07D487/04
摘要： The present application relates to novel substituted (aza)pyridopyrazolopyrimidinones and indazolopyrimidinones, to processes for their preparation, the compounds for use alone or in combinations in a method for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of acute and recurrent bleeding in patients with or without underlying hereditary or acquired bleeding disorders, wherein the bleeding is associated with a disease or medical intervention selected from the group consisting of menorrhagia, postpartum hemorrhage, hemorrhagic shock, trauma, surgery, transplantation, stroke, liver diseases, hereditary angioedema, nosebleed, and synovitis and cartilage damage following hemarthrosis.
-
-
-
-
搜索结果
5 条记录 (耗时 0.031 秒)
